Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2019 1
2020 1
2021 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
Extraosseous pericardial Ewing's sarcoma.
Azribi F, Razak AR, Bough G, Lee D, Rowe D, Bown N, Dildey P, Clark S, Plummer R. Azribi F, et al. J Clin Oncol. 2010 Feb 1;28(4):e48-50. doi: 10.1200/JCO.2009.23.7487. Epub 2009 Nov 16. J Clin Oncol. 2010. PMID: 19917868 No abstract available.
Rare case of chemotherapy-refractory metastatic vaginal squamous cell carcinoma with complete response to concurrent pembrolizumab and radiotherapy- case report and literature review.
Ansari J, Eltigani Mohmmed Y, Ghazal-Aswad S, Ansari H, Akhter SMJ, Hassoun Hadid O, Rizwan S, Almazrouei R, Dawoud E, Azribi F, Elhasin H, Kumar P, Al Sumaida AR, Al-Qawasmeh K, Glaholm J, Hochmair MJ, Hussain S, Balaraj K. Ansari J, et al. Among authors: azribi f. Gynecol Oncol Rep. 2021 Oct 8;38:100878. doi: 10.1016/j.gore.2021.100878. eCollection 2021 Nov. Gynecol Oncol Rep. 2021. PMID: 34926759 Free PMC article.
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).
Bachelot T, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Bondarenko I, Paluch-Shimon S, Wardley A, Merot JL, du Toit Y, Easton V, Lindegger N, Miles D; PERUSE investigators. Bachelot T, et al. Ann Oncol. 2019 May 1;30(5):766-773. doi: 10.1093/annonc/mdz061. Ann Oncol. 2019. PMID: 30796821 Free article. Clinical Trial.
The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force.
Al-Shamsi H, Darr H, Abu-Gheida I, Ansari J, McManus MC, Jaafar H, Tirmazy SH, Elkhoury M, Azribi F, Jelovac D, Doufan TA, Labban AR, Basha AA, Samir A, Maarraoui A, Al Dameh A, Al-Awadhi A, Al Haj Ali B, Aboud B, Elshorbagy D, Trad D, Abdul Jabbar D, Hamza D, Ashtar E, Dawoud E, Aleassa EM, Khan F, Iqbal F, Abdellatif H, Afrit M, Masri MH, Abuhaleeqa M, Alfalasi M, Omara M, Diab M, Latif MF, Oner M, Dreier N, Almarzouqi O, Singarachari RA, Bendardaf R, Alrawi S, Aldeen SS, Rana S, Talima S, Abdelgawad T, Ahluwalia A, Alkasab T, Madi T, Alkhouri T, Ul Haq U, Alabed YZ, Azzam M, Ali Z, Abbas MA, Razek AA, Al-Khatib F. Al-Shamsi H, et al. Among authors: azribi f. Gulf J Oncolog. 2020 Jan;1(32):71-87. Gulf J Oncolog. 2020. PMID: 32342923